SANOFI INDIA
|
The Current P/E Ratio of SANOFI INDIA is 29.87.
Share Price | ₹4,707.9 | Oct 03,2025 |
Market Cap | ₹10,828.1 Cr | |
Earnings-TTM | ₹362.5 Cr | TTM-Standalone Results |
Price/Earnings | 29.87x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SANOFI INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹10,828.1 Cr] as on Oct 03,2025
(/) Earnings [ ₹362.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 29.87x ]
Thus, for SANOFI INDIA , the investors are currently willing to pay 29.87 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SANOFI INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SANOFI INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of SANOFI INDIA
PE Ratio Performance Analysis for SANOFI INDIA
- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2024 to Dec2020 averaged 35.35x.
- SANOFI INDIA 's operated at median p/e ratio of 40.06x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2023 at 50.89x.
- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2021 of 19.22x.
How does SANOFI INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SANOFI INDIA | 362.50 | 29.87 | 10,828.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.66 | 392,063.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 67.54 | 155,749.0 |
CIPLA LTD | 5,406.81 | 22.64 | 122,429.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 59.40 | 118,928.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.19 | 104,168.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.05 | 101,089.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.45 | 99,491.4 |
LUPIN LTD | 3,722.18 | 24.20 | 90,072.6 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.58 | 63,516.5 |
ABBOTT INDIA LTD | 1,452.29 | 43.81 | 63,629.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SANOFI INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.19x |
Max industry PE | 67.54x |
Median industry PE | 29.87x |
Average industry PE | 36.04x |
You may also like the below Video Courses